36105327|t|Multicomponent Macrocyclic IL-17a Modifier.
36105327|a|IL-17a is a major inflammation target, with several approved antibodies in clinical use. Small-molecule IL-17a antagonists are an emerging hot topic, with the recent advancement of three compounds into clinical trials. Here, we describe the design, discovery, synthesis, and screening of macrocyclic compounds that bind to IL-17a. We found that all currently described IL-17a modifiers belong to the same pharmacophore model, likely resulting in a similar receptor binding mode on IL-17a. A pipeline of pharmacophore analysis, virtual screening, resynthesis, and protein biophysics resulted in a potent IL-17a macrocyclic modifier.
36105327	27	33	IL-17a	Gene	3605
36105327	44	50	IL-17a	Gene	3605
36105327	62	74	inflammation	Disease	MESH:D007249
36105327	148	154	IL-17a	Gene	3605
36105327	367	373	IL-17a	Gene	3605
36105327	413	419	IL-17a	Gene	3605
36105327	525	531	IL-17a	Gene	3605
36105327	647	653	IL-17a	Gene	3605
36105327	Association	MESH:D007249	3605

